Population
Knockin mouse model expressing the human catecholaminergic polymorphic ventricular tachycardia-associated…
Comparison
Dantrolene vs Wild-type mice/cardiomyocytes and untreated…
Design
Preclinical
Key result
The S2246L mutation in RyR2 causes defective interdomain interactions leading to erroneous Ca2+ channel activation and exercise-induced ventricular tachycardia, which was stopped by dantrolene.
Authors
Loading...
Dantrolene suppressed VT in S2246L mice; hypothesis-generating for CPVT therapy, should not yet change practice.
The S2246L mutation in RyR2 causes CPVT through defective interdomain interactions that lead to aberrant diastolic Ca2+ release, a mechanism that can be reversed by dantrolene.
Suetomi et al. (2011) studied Catecholaminergic polymorphic ventricular tachycardia. S2246L mutation in RyR2 vs. Wild-type was evaluated on Ventricular tachycardia after exercise and Ca2+ spark frequency. The S2246L mutation in RyR2 causes defective interdomain interactions leading to erroneous Ca2+ channel activation and exercise-induced ventricular tachycardia, which was stopped by dantrolene.